COVID-19: Implications for bipolar disorder clinical care and research
The COVID-19 pandemic has posed significant challenges to health care globally, and individuals with bipolar disorder are likely disproportionally affected. Based on review of literature and collective clinical experience, we discuss that without special intervention, individuals with bipolar disord...
Main Authors: | Siqi Xue, M Ishrat Husain, Abigail Ortiz, M Omair Husain, Zafiris J Daskalakis, Benoit H Mulsant |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312120981178 |
Similar Items
-
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
by: Brett D. M. Jones, et al.
Published: (2021-08-01) -
The Impact of COVID-19 on Psychiatric Emergency and Inpatient Services in the First Month of the Pandemic in a Large Urban Mental Health Hospital in Ontario, Canada
by: Helena K. Kim, et al.
Published: (2021-04-01) -
Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study
by: Tyler S. Kaster, et al.
Published: (2018-01-01) -
The role of anti-inflammatory agents in the treatment of mood disorders
by: Husain, Muhammad Ishrat
Published: (2018) -
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
by: Muhammad Ishrat Husain, et al.
Published: (2020-04-01)